89bio, Inc. — Investor Relations & Filings
Filings indexed
549
across all filing types
Latest filing
2026-02-13
Major Shareholding Noti…
Country
US
United States of America
Listing
US
ETNB
89bio, Inc. is a clinical-stage biopharmaceutical company that develops therapies for liver and cardiometabolic diseases. The company's lead product candidate, pegozafermin, is a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21). It is being developed for the treatment of non-alcoholic steatohepatitis (NASH) and severe hypertriglyceridemia (SHTG). The company focuses on creating innovative and potentially best-in-class treatments to address unmet medical needs in its target patient populations.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| SCHEDULE 13G/A Filing | 2026-02-13 | English | |
| Regulatory Filings 2025 | 2025-11-20 | English | |
| Major Shareholding Notification 2025 | 2025-11-14 | English | |
| Major Shareholding Notification 2025 | 2025-11-14 | English | |
| Major Shareholding Notification 2025 | 2025-11-13 | English | |
| 15-12G | 2025-11-10 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
1 filing
| |||||
| 31702524 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
|
2025
14 filings
| |||||
| 13197454 | Regulatory Filings 2025 | 2025-11-20 | English | ||
| 13197455 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 13197456 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 13197457 | Major Shareholding Notification 2025 | 2025-11-13 | English | ||
| 13197458 | 15-12G | 2025-11-10 | English | ||
| 13197459 | Major Shareholding Notification 2025 | 2025-11-03 | English | ||
| 13197460 | Director's Dealing 2025 | 2025-11-03 | English | ||
| 13197461 | Major Shareholding Notification 2025 | 2025-10-31 | English | ||
| 13197462 | 4 | 2025-10-30 | English | ||
| 13197463 | 4 | 2025-10-30 | English | ||
| 13197464 | 4 | 2025-10-30 | English | ||
| 13197465 | 4 | 2025-10-30 | English | ||
| 13197466 | 4 | 2025-10-30 | English | ||
| 13197467 | 4 | 2025-10-30 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Arcturus Therapeutics Holdings Inc.
A commercial-stage mRNA medicines company focused on rare a…
|
ARCT | US | Manufacturing |
|
Arcus Biosciences, Inc.
A clinical-stage biopharmaceutical company developing combi…
|
RCUS | US | Manufacturing |
|
Arcutis Biotherapeutics, Inc.
Develops and commercializes treatments for immune-mediated …
|
ARQT | US | Manufacturing |
|
ARDELYX, INC.
Biopharmaceutical company developing medicines for cardiore…
|
ARDX | US | Manufacturing |
|
ARECOR THERAPEUTICS PLC
Biopharmaceutical company enhancing medicines with its prop…
|
AREC | GB | Manufacturing |
|
ARGENT BIOPHARMA LIMITED
Develops plant-inspired and synthetic medicines for neurolo…
|
RGT | AU | Manufacturing |
|
argenx SE
Develops and commercializes antibody-based therapies for se…
|
1AE | NL | Manufacturing |
|
Armata Pharmaceuticals, Inc.
Develops bacteriophage therapeutics for antibiotic-resistan…
|
ARMP | US | Manufacturing |
|
AroCell AB
Develops and markets in vitro diagnostic (IVD) tests for on…
|
AROC | SE | Manufacturing |
|
ArriVent BioPharma, Inc.
Clinical-stage biopharma developing oncology drugs for diff…
|
AVBP | US | Manufacturing |
89bio, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31613/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31613 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31613 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31613 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31613}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for 89bio, Inc. (id: 31613)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.